Cargando…
Blood monocyte-derived CD169(+) macrophages contribute to antitumor immunity against glioblastoma
Infiltrating tumor-associated macrophages (TAM) are known to impede immunotherapy against glioblastoma (GBM), however, TAMs are heterogeneous, and there are no clear markers to distinguish immunosuppressive and potentially immune-activating populations. Here we identify a subset of CD169(+) macropha...
Autores principales: | Kim, Hyun-Jin, Park, Jang Hyun, Kim, Hyeon Cheol, Kim, Chae Won, Kang, In, Lee, Heung Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585054/ https://www.ncbi.nlm.nih.gov/pubmed/36266311 http://dx.doi.org/10.1038/s41467-022-34001-5 |
Ejemplares similares
-
A Higher Frequency of CD14(+)CD169(+) Monocytes/Macrophages in Patients with Colorectal Cancer
por: Li, Chenguang, et al.
Publicado: (2015) -
Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes
por: Asano, Kenichi, et al.
Publicado: (2015) -
Protocol to analyze antitumor immunity of orthotopic injection and spontaneous murine high-grade glioma models using flow cytometry and single-cell RNA sequencing
por: Park, Jang Hyun, et al.
Publicado: (2022) -
Transient Depletion of CD169(+) Cells Contributes to Impaired Early Protection and Effector CD8(+) T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection
por: Oh, Dong Sun, et al.
Publicado: (2017) -
Functions of CD169 positive macrophages in human diseases (Review)
por: Liu, Yu, et al.
Publicado: (2021)